* To use proceeds to make acquisitions, repay debt
* Expects to trade on Nasdaq Global Markets under symbol
June 8 Medical device company Tornier B.V.
filed with the U.S. regulators on Tuesday to raise up to $205
million in an initial public offering.
The Netherlands-based company said it will use the net
proceeds to repay debt. It may use the proceeds to acquire
other businesses, products or technologies, the company added.
For the first quarter, net loss attributable to common
stockholders was $10 million, or 14 cents a share, compared
with a loss of $3.5 million, or 5 cents a share, in the same
period last year.
The company said it is focused on surgeons that treat
musculoskeletal injuries and disorders of the shoulder, elbow,
wrist, hand, ankle and foot.
In some international markets, the company also offers
joint replacement products for the hip and knee, Tornier said,
which sells over 70 product lines in about 35 countries.
The underwriters on the offering are being led by Merrill
Lynch, Pierce, Fenner & Smith Inc and J.P. Morgan Securities.
The company is expected to trade on Nasdaq Global Market
under the symbol "TRNX."
(Reporting by Archana Shankar in Bangalore; Editing by Jarshad